John D. Ratliff
2017 - Laboratory Corp. of America Holdings
In 2017, John D. Ratliff earned a total compensation of $5M as Executive Vice President, Chief Executive Officer of Covance Drug Development at Laboratory Corp. of America Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $648,415 |
|---|---|
| Option Awards | $697,573 |
| Salary | $659,750 |
| Stock Awards | $2,978,743 |
| Other | $13,035 |
| Total | $4,997,516 |
Ratliff received $3M in stock awards, accounting for 60% of the total pay in 2017.
Ratliff also received $648.4K in non-equity incentive plan, $697.6K in option awards, $659.8K in salary and $13K in other compensation.
Rankings
In 2017, John D. Ratliff's compensation ranked 1,894th out of 14,666 executives tracked by ExecPay. In other words, Ratliff earned more than 87.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,894 out of 14,666 | 87th |
Division Services | 372 out of 2,424 | 85th |
Major group Health Services | 21 out of 224 | 91st |
Industry group Medical And Dental Laboratories | 4 out of 64 | 94th |
Industry Medical Laboratories | 4 out of 64 | 94th |
Source: SEC filing on March 29, 2019.
Ratliff's colleagues
We found four more compensation records of executives who worked with John D. Ratliff at Laboratory Corp. of America Holdings in 2017.
2017
DAVID KING
Laboratory Corp. of America Holdings
Chief Executive Officer
2017
Gary Huff
Laboratory Corp. of America Holdings
Chief Executive Officer
2017
GLENN EISENBERG
Laboratory Corp. of America Holdings
Chief Financial Officer
2017
F EBERTS
Laboratory Corp. of America Holdings